Overview

The University of Washington Engineered Biomaterials Consortium is a three-way partnership between the US government, the University of Washington and more than 2 dozen industrial sponsors. Together, these corporate entities and other laboratories share the benefit of their pooled resources as well as a high degree of leveraged funding. The National Science Foundation is providing a total of $25 million and the UW has provided a group of more than a dozen laboratories that make of the infrastructure of UWEB.

UWEB's mission is to provide our industrial sponsors the keys that unlock their problems in biocompatibility and the healing of medical devices. These revolutionary advances in biomaterials provide our sponsors with engineered systems for the manufacturing and marketing of next-generation products.

The future product portfolios of UWEB Sponsors will contain such things as vascular grafts that become fully endothelialized and forgo a state of chronic inflammation. Bioprosthetic heart valves that no longer succumb to ectopic calcification and contact lenses that resist biofouling and macrophage infiltration are just a couple of products poised to make a quantum leap forward in the coming years. Implantable biosensors and artificial organs will be here also to enrich and benefit the lives of scores of thousands of us. The science and engineering design principles for this revolution are all happening right now in UWEB.

By analogy, think of your company's current challenges with these issues. Next, think of UWEB as a router, to borrow a term from the computer industry. UWEB has generated, over the past four years, sufficient bandwidth to direct your design traffic into your products and on to your customers.

Your company's long and short term challenges belong here at UWEB where they can be plugged into our network of modern molecular medicine, materials science and a large cache of some of the worlds foremost thought leaders.

UWEB - a multidisciplinary system targeted to solve multi-faceted issues challenging the medical device and diagnostics industries.